1. Home
  2. CRBU vs TOUR Comparison

CRBU vs TOUR Comparison

Compare CRBU & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • TOUR
  • Stock Information
  • Founded
  • CRBU 2011
  • TOUR 2006
  • Country
  • CRBU United States
  • TOUR China
  • Employees
  • CRBU N/A
  • TOUR N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • TOUR Transportation Services
  • Sector
  • CRBU Health Care
  • TOUR Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • TOUR Nasdaq
  • Market Cap
  • CRBU 93.0M
  • TOUR 101.2M
  • IPO Year
  • CRBU 2021
  • TOUR 2014
  • Fundamental
  • Price
  • CRBU $0.74
  • TOUR $0.88
  • Analyst Decision
  • CRBU Strong Buy
  • TOUR
  • Analyst Count
  • CRBU 5
  • TOUR 0
  • Target Price
  • CRBU $11.80
  • TOUR N/A
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • TOUR 197.4K
  • Earning Date
  • CRBU 05-06-2025
  • TOUR 06-03-2025
  • Dividend Yield
  • CRBU N/A
  • TOUR 4.11%
  • EPS Growth
  • CRBU N/A
  • TOUR N/A
  • EPS
  • CRBU N/A
  • TOUR 0.09
  • Revenue
  • CRBU $9,994,000.00
  • TOUR $70,367,853.00
  • Revenue This Year
  • CRBU N/A
  • TOUR $16.99
  • Revenue Next Year
  • CRBU $163.34
  • TOUR $13.23
  • P/E Ratio
  • CRBU N/A
  • TOUR $10.14
  • Revenue Growth
  • CRBU N/A
  • TOUR 16.40
  • 52 Week Low
  • CRBU $0.66
  • TOUR $0.70
  • 52 Week High
  • CRBU $4.21
  • TOUR $1.76
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 34.01
  • TOUR 34.69
  • Support Level
  • CRBU $0.71
  • TOUR $0.85
  • Resistance Level
  • CRBU $0.94
  • TOUR $0.90
  • Average True Range (ATR)
  • CRBU 0.10
  • TOUR 0.06
  • MACD
  • CRBU 0.00
  • TOUR -0.01
  • Stochastic Oscillator
  • CRBU 23.44
  • TOUR 23.75

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.

Share on Social Networks: